vs
Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $58.0M, roughly 1.4× indie Semiconductor, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -53.8%, a 15.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.3%).
indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
INDI vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $83.1M |
| Net Profit | $-31.2M | $-31.6M |
| Gross Margin | 37.3% | 64.9% |
| Operating Margin | -58.5% | -4.1% |
| Net Margin | -53.8% | -38.1% |
| Revenue YoY | -0.0% | 20.2% |
| Net Profit YoY | 9.1% | -27.9% |
| EPS (diluted) | $-0.16 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $58.0M | $76.4M | ||
| Q3 25 | $53.7M | $83.3M | ||
| Q2 25 | $51.6M | $79.2M | ||
| Q1 25 | $54.1M | $69.2M | ||
| Q4 24 | $58.0M | $68.2M | ||
| Q3 24 | $54.0M | $58.4M | ||
| Q2 24 | $52.4M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-31.2M | $-29.8M | ||
| Q3 25 | $-38.3M | $-21.4M | ||
| Q2 25 | $-39.0M | $-19.6M | ||
| Q1 25 | $-34.5M | $-24.7M | ||
| Q4 24 | $-34.4M | $-18.9M | ||
| Q3 24 | $-49.7M | $-21.0M | ||
| Q2 24 | $-19.2M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 37.3% | 60.6% | ||
| Q3 25 | 40.1% | 64.8% | ||
| Q2 25 | 40.6% | 65.4% | ||
| Q1 25 | 41.7% | 63.9% | ||
| Q4 24 | 42.6% | 64.0% | ||
| Q3 24 | 39.3% | 63.2% | ||
| Q2 24 | 42.2% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -58.5% | -40.6% | ||
| Q3 25 | -71.4% | -27.8% | ||
| Q2 25 | -83.3% | -28.0% | ||
| Q1 25 | -72.0% | -39.7% | ||
| Q4 24 | -58.4% | -28.9% | ||
| Q3 24 | -92.5% | -38.4% | ||
| Q2 24 | -70.0% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -53.8% | -39.1% | ||
| Q3 25 | -71.3% | -25.7% | ||
| Q2 25 | -75.6% | -24.7% | ||
| Q1 25 | -63.9% | -35.8% | ||
| Q4 24 | -59.2% | -27.6% | ||
| Q3 24 | -92.1% | -35.9% | ||
| Q2 24 | -36.6% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.16 | $-0.54 | ||
| Q3 25 | $-0.19 | $-0.38 | ||
| Q2 25 | $-0.20 | $-0.35 | ||
| Q1 25 | $-0.18 | $-0.45 | ||
| Q4 24 | $-0.18 | $-0.34 | ||
| Q3 24 | $-0.28 | $-0.40 | ||
| Q2 24 | $-0.11 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $145.5M | $245.6M |
| Total DebtLower is stronger | $353.4M | $51.7M |
| Stockholders' EquityBook value | $358.0M | $347.7M |
| Total Assets | $840.8M | $487.1M |
| Debt / EquityLower = less leverage | 0.99× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $145.5M | $286.5M | ||
| Q3 25 | $160.9M | $294.3M | ||
| Q2 25 | $192.6M | $302.7M | ||
| Q1 25 | $236.6M | $316.2M | ||
| Q4 24 | $274.2M | $333.7M | ||
| Q3 24 | $96.9M | $196.8M | ||
| Q2 24 | $112.3M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $353.4M | $51.6M | ||
| Q3 25 | $353.5M | $51.6M | ||
| Q2 25 | $352.5M | $51.5M | ||
| Q1 25 | $379.0M | $51.5M | ||
| Q4 24 | $381.3M | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $358.0M | $365.9M | ||
| Q3 25 | $369.2M | $380.3M | ||
| Q2 25 | $390.4M | $385.8M | ||
| Q1 25 | $405.6M | $389.2M | ||
| Q4 24 | $417.9M | $402.2M | ||
| Q3 24 | $458.6M | $241.2M | ||
| Q2 24 | $470.7M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $840.8M | $508.1M | ||
| Q3 25 | $855.1M | $511.5M | ||
| Q2 25 | $867.6M | $513.1M | ||
| Q1 25 | $909.0M | $519.4M | ||
| Q4 24 | $941.4M | $534.0M | ||
| Q3 24 | $797.5M | $374.1M | ||
| Q2 24 | $797.3M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.99× | 0.14× | ||
| Q3 25 | 0.96× | 0.14× | ||
| Q2 25 | 0.90× | 0.13× | ||
| Q1 25 | 0.93× | 0.13× | ||
| Q4 24 | 0.91× | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.4M | — |
| Free Cash FlowOCF − Capex | $-16.1M | — |
| FCF MarginFCF / Revenue | -27.8% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-71.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-14.4M | $-10.3M | ||
| Q3 25 | $-6.2M | $-6.6M | ||
| Q2 25 | $-7.6M | $-15.0M | ||
| Q1 25 | $-29.0M | $-17.0M | ||
| Q4 24 | $-6.7M | $-32.4M | ||
| Q3 24 | $-22.8M | $-18.8M | ||
| Q2 24 | $-19.7M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-16.1M | $-12.2M | ||
| Q3 25 | $-10.3M | $-9.5M | ||
| Q2 25 | $-13.6M | $-17.8M | ||
| Q1 25 | $-31.4M | $-18.8M | ||
| Q4 24 | $-8.6M | $-33.6M | ||
| Q3 24 | $-29.3M | $-19.0M | ||
| Q2 24 | $-23.4M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | -27.8% | -15.9% | ||
| Q3 25 | -19.2% | -11.4% | ||
| Q2 25 | -26.4% | -22.5% | ||
| Q1 25 | -58.0% | -27.2% | ||
| Q4 24 | -14.8% | -49.2% | ||
| Q3 24 | -54.3% | -32.6% | ||
| Q2 24 | -44.7% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 7.8% | 3.4% | ||
| Q2 25 | 11.6% | 3.5% | ||
| Q1 25 | 4.4% | 2.7% | ||
| Q4 24 | 3.2% | 1.7% | ||
| Q3 24 | 12.1% | 0.4% | ||
| Q2 24 | 7.0% | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
